About Zyon Ayni
Zyon Ayni is the founder and CEO of Code Pharma, a Dutch pharmaceutical company in the development of Gammora. Zyon was born in 1973 in Israel but owned both Israeli and Dutch citizenship. Zyon is in a relationship, and he is the father of two children.
Developed by Code Pharma, Gammora is designed to block HIV by destroying infected cells and replacing them with healthy CD4 cells, as demonstrated in clinical trials. The treatment uses a synthetic peptide that forces infected cells to self-destruct without harming healthy ones.
Between Israel And The Netherlands
Zyon Ayni is both a citizen of Israel and the Netherlands. Though he was born in Israel, his life between Israel and the Netherlands started at age 6 when he travelled alongside his family for the first time to the Netherlands. Over the next five years, Zyon continued to frequent the Netherlands until he finally decided to leave his studies in Israel and relocate to the Netherlands at 13.
His decision to relocate to the Netherlands is to participate in the family businesses. Over the years, Zyon Ayni discovered his passion for business and entrepreneurship due to his involvement in several businesses at a very tender age. As a young boy, he was in charge of income calculations, expenses management, procurements, and worthwhile purchases.
At 32, he had founded the third-largest restaurant and leisure business empire in Amsterdam, where he employed hundreds of people and created a source of livelihood for dozens of families.
Zyon Ayni’s Life-Changing Moments
Zyon changed the course of his life after an encounter he had in 2010. It was a routine appointment with a dentist in Israel. While waiting for the doctor, he picked a magazine where came across an article detailing the discovery from scientists in the Hebrew University of Israel. The scientists had just discovered a special mechanism that could destroy cells infected with HIV. More so, it was specified in the article that the Hebrew University was also looking for investors who could help develop the discovery into a medicine.
There and then, Zyon Ayni saw the opportunity and decided to pursue it. According to one of Zyon’s previous interviews, the article in the magazine presented him with an opportunity that could change the world. Though many naysayers said it was an impossible fantasy, Zyon never gave up, and he eventually made the investment from his capital. Flash forward to 2014, Zyon founded Code Pharma, and the company launched in collaboration with Professor Abraham Loyter of the Hebrew University of Jerusalem.
Other Involvements
Zyon is a philanthropist that has been involved in several humanitarian services across Africa. He provides help and assistance across the continent of Africa, helping the less privileged by financing the expenses of orphaned children, housing them, and paying their tuition fees. He is also an active martial arts lover and professional fighter who has maintained his passion and skills for Muay Thai (Thai boxing) over the years.
Latest Posts
“Patients who received the medicine exhibited significant enhancement” | ynet
Dr. Eynat Finkelshtein, Chief Scientific Officer at Code Pharma, featured on ynet TV to discuss Codivir: “When the Covid-19 appeared, we wanted to explore whether
Zyon Ayni is the Hua Hin Muay Thai Champion
Zyon Ayni, the 48-year-old Israeli-Dutch entrepreneur and CEO of Code Pharma, claimed the Hua Hin Muay Thai Champion after defeating local champion Pet Pai Lin.
IsuueWire: Code Pharma Announces a Limited Fundraising Round
According to IssueWire, “Code Pharma plans to launch an Initial Public Offering (IPO) on the NASDAQ and Switzerland’s SIX Swiss Exchange. The company had launched
